Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
HKU Bridge Technology is a specialized biotechnology and technology transfer entity associated with the University of Hong Kong (HKU). The company serves as a commercialization vehicle for high-potential life science research originating from the university's laboratories, focusing on bridging the gap between academic discovery and clinical application. Its portfolio encompasses a diverse range of therapeutic areas, including infectious diseases, oncology, and advanced medical devices. By leveraging the intellectual property and scientific expertise of HKU, the company aims to accelerate the development of innovative healthcare solutions for global markets. HKU Bridge Technology actively seeks partnerships with global pharmaceutical companies and investors to advance its pipeline through clinical trials.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on HKU Bridge Technology.